葛兰素史克(US)吧
排序:
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
226 0 资讯 葛兰素史克副总裁、中国总经理余慧明:感受到中国经济 葛兰素史克(US)资讯 03-07 21:53
25 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 03-07 20:11
22 0 公告 Filing under Securities Act Rules 163/433 of free 葛兰素史克(US)资讯 03-07 19:36
60 0 这两周,走势亮眼 云中11011 03-07 07:23
27 0 公告 Prospectus [Rule 424(b)(2)] 葛兰素史克(US)资讯 03-06 22:02
25 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 03-06 20:23
2808 10 接入DS+疫苗出海,艾美疫苗已成港股生物科技赛道“性 明大教主 03-06 08:44
26 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 03-05 19:21
27 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 03-04 19:10
25 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 03-04 01:50
29 0 公告 Annual and transition report of foreign private is 葛兰素史克(US)资讯 03-04 00:24
23 0 公告 Notice of disclosure filed pursuant to Section 219 葛兰素史克(US)资讯 03-04 00:24
27 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 03-03 23:28
24 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 03-03 20:01
25 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 03-03 19:34
24 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 03-03 19:23
177 0 怎么这么安静,没人啊 云中11011 03-01 16:34
24 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-28 19:35
25 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-27 19:45
23 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-27 19:38
29 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-27 01:19
23 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-26 19:17
26 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-25 19:37
25 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-24 19:45
27 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-24 19:37
164 0 资讯 葛兰素史克启动股票回购计划,首批回购金额高达7亿英 葛兰素史克(US)资讯 02-24 15:58
25 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-22 00:57
27 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-22 00:50
25 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-22 00:35
27 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-22 00:23
27 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-22 00:04
23 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-21 20:26
31 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-21 20:19
41 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-20 19:47
58 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-18 19:43
88 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-14 03:03
111 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-12 03:06
367 1 “爆款”创新药,MNC还有哪些储备? 药创新 02-11 10:51
341 0 确确点37.514收盘 深谷幽景 02-06 02:27
277 0 洗好睡吧37.51收盘 深谷幽景 02-06 02:24
147 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-06 01:00
408 0 资讯 葛兰素史克美股盘前涨逾5% 葛兰素史克(US)资讯 02-05 17:22
152 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 02-05 11:55
193 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 01-28 19:22
193 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 01-28 19:10
195 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 01-27 20:28
228 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 01-21 20:00
236 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 01-17 00:27
242 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 01-16 02:02
247 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 01-15 01:19
233 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 01-14 00:51
233 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 01-13 20:33
503 0 资讯 葛兰素史克HIV暴露前预防长效药物卡替拉韦注射液在国 葛兰素史克(US)资讯 01-10 21:29
460 0 资讯 HIV暴露前预防长效药物卡替拉韦注射液在中国上市 葛兰素史克(US)资讯 01-10 20:02
237 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 01-10 19:56
571 0 资讯 葛兰素史克HIV暴露前预防长效药物艾普特在中国上市 葛兰素史克(US)资讯 01-10 13:52
465 0 资讯 葛兰素史克据悉接近以10亿美元收购私有生物技术公司ID 葛兰素史克(US)资讯 01-09 12:40
589 0 资讯 葛兰素史克洽谈收购生物科技公司IDRx 接近就潜在的10 葛兰素史克(US)资讯 01-09 03:13
1552 1 资讯 美国食品药品管理局(FDA)表示:葛兰素史克与辉瑞制 葛兰素史克(US)资讯 01-08 07:05
237 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 01-07 19:37
581 0 资讯 葛兰素史克:新可来在中国获批用于治疗成人慢性鼻窦炎 葛兰素史克(US)资讯 01-03 23:32
256 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 01-03 20:30
410 0 资讯 葛兰素史克美泊利珠单抗注射液在华获批新适应症 葛兰素史克(US)资讯 01-03 15:28
224 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 01-02 23:10
254 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 12-24 01:58
248 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 12-20 23:41
253 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 12-20 23:32
255 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 12-16 22:37
250 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 12-16 22:08
237 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 12-16 21:30
259 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 12-13 00:20
266 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 12-10 03:45
239 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 12-09 21:08
244 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 12-09 21:02
2029 2 智飞生物与GSK的两个产品和两个十年,风险大大解除 成长企业常识 12-09 10:03
246 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 12-05 19:06
613 0 资讯 映恩生物与GSK达成约10亿美元独家授权协议 葛兰素史克(US)资讯 12-05 12:54
499 0 资讯 GSK超10亿美元“扫货”映恩生物 ADC领域下一步趋势如 葛兰素史克(US)资讯 12-04 20:08
发表新主题
悬赏提问
帖子不见了!怎么办?   
   请登录 登录 | 5秒注册 作者: 退出 
郑重声明:用户在社区发表的所有资料、言论等仅代表个人观点,与本网站立场无关,不对您构成任何投资建议。用户应基于自己的独立判断,自行决定证券投资并承担相应风险。《东方财富社区管理规定》

扫一扫下载APP

扫一扫下载APP
信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-34289898 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500